myVax
Centralized Vaccine Tracking
Services
Industry
Healthcare
Project Background
MyVax is a prominent Malaysian biotechnology and pharmaceutical manufacturer that operates a fully equipped, Good Manufacturing Practice (GMP)-certified facility. Specializing in the development of biosimilars, biological medical products highly similar to already approved reference medicines, and other advanced pharmaceuticals, they play a critical role in the region's healthcare infrastructure. Recognized by Malaysian science and regulatory authorities for their contributions to local vaccine development, MyVax also operates a robust wholesale distribution network for medical goods across Southeast Asia.
Challenges
The existing landscape for evaluating, approving, and auditing pharmaceutical and consumer biological products in Malaysia is severely burdened by administrative inefficiencies. The traditional workflow relies heavily on manual, paper-based verification procedures scattered across disconnected entities, leading to significant market-entry delays and increased risk of human error. For manufacturers and distributors, navigating this fragmented system is incredibly frustrating; the lack of a centralized tracking mechanism means they cannot easily monitor the real-time status of their product approvals. Furthermore, this lack of transparency makes it difficult to securely audit the supply chain, leaving the market vulnerable to compliance blind spots and potential distribution inconsistencies.
Problem solving with design thinking workshop
Key features
Centralized Digital Registration
A unified portal where manufacturers and distributors can securely submit product documentation, batch numbers, and chemical compositions online, shifting away from fragmented physical paperwork.
Instant QR Code Verification
An integrated digital scanning feature allowing users to utilize a mobile camera to read product QR codes, pulling up instantaneous real-time verification data from the central database.
Automated E-Certificate Issuance
A secure cryptographic engine that automatically generates and issues electronic compliance certificates (e-certs) to distributors immediately upon batch verification approval.
Granular Role-Based Access Control
A strict security hierarchy that ensures manufacturers, regulatory bodies, and distributors only see data relevant to their specific clearance level, protecting proprietary pharmaceutical formulas.
Real-Time Approval Tracking Dashboard
An interactive, user-friendly dashboard allowing stakeholders to view the exact bottleneck or phase their products are currently experiencing during the validation pipeline.
The impact
Drastic Acceleration of Time-to-Market
By replacing manual document hand-offs with instant digital scanning and automated e-certs, the time required to approve and distribute critical medical goods was cut by days.
Enhanced Supply Chain Traceability
The introduction of unique QR identification provides a transparent, unalterable digital audit trail, drastically minimizing the risk of counterfeit or unverified medical batches entering the market.
Operational Overhead Reduction
Centralizing information reduced administrative labor, eliminated physical filing errors, and lowered compliance management costs for both MyVax and its network of distributors.
Conclusion
By consolidating fragmented manual operations into a unified digital ecosystem, Lizard Global successfully transformed MyVax's product lifecycle from a slow, paper-heavy process into a highly visible, automated pipeline. Replacing manual checks with instant QR code scanning and automated electronic certification not only eliminates administrative bottlenecks but also builds an unbreakable chain of trust between biotech manufacturers, distributors, and Malaysian regulatory bodies. Ultimately, this centralized approach establishes a modernized blueprint for pharmaceutical distribution where transparency, regulatory safety, and speed coexist seamlessly.
Visit myVax's website
Similar projects like myVax
Stuck between a great idea and the right team to build it?Let's talk.
We work with corporate innovation teams and ambitious scale-ups across the Netherlands, Singapore, and Australia, and wherever great software needs to be built. Drop us a message and we'll get back to you within one business day.
Markus Monnikendam
Global Commercial Director
hello@lizard.global